A detailed history of Geode Capital Management, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,543,228 shares of VXRT stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,543,228
Previous 2,196,503 15.79%
Holding current value
$1.37 Million
Previous $1.47 Million 46.91%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.58 - $0.99 $201,100 - $343,257
346,725 Added 15.79%
2,543,228 $2.16 Million
Q2 2024

Aug 09, 2024

BUY
$0.53 - $1.3 $833 - $2,044
1,573 Added 0.07%
2,196,503 $1.47 Million
Q1 2024

May 13, 2024

BUY
$0.56 - $1.41 $130,422 - $328,384
232,897 Added 11.87%
2,194,930 $2.85 Million
Q4 2023

Feb 13, 2024

BUY
$0.57 - $0.85 $99,976 - $149,088
175,398 Added 9.82%
1,962,033 $1.12 Million
Q3 2023

Nov 13, 2023

BUY
$0.69 - $0.85 $150,230 - $185,067
217,726 Added 13.88%
1,786,635 $1.34 Million
Q2 2023

Aug 11, 2023

SELL
$0.6 - $1.41 $656,138 - $1.54 Million
-1,093,564 Reduced 41.07%
1,568,909 $1.15 Million
Q1 2023

May 15, 2023

BUY
$0.71 - $1.25 $58,893 - $103,686
82,949 Added 3.22%
2,662,473 $2.02 Million
Q4 2022

Feb 13, 2023

BUY
$0.75 - $2.24 $236,946 - $707,678
315,928 Added 13.96%
2,579,524 $2.48 Million
Q3 2022

Nov 14, 2022

BUY
$2.09 - $4.5 $79,629 - $171,450
38,100 Added 1.71%
2,263,596 $4.93 Million
Q2 2022

Aug 12, 2022

SELL
$2.7 - $5.28 $22,191 - $43,396
-8,219 Reduced 0.37%
2,225,496 $7.79 Million
Q1 2022

May 13, 2022

BUY
$4.29 - $6.64 $602,062 - $931,864
140,341 Added 6.7%
2,233,715 $11.3 Million
Q4 2021

Feb 11, 2022

SELL
$5.77 - $7.96 $108,862 - $150,181
-18,867 Reduced 0.89%
2,093,374 $13.1 Million
Q3 2021

Nov 12, 2021

BUY
$6.67 - $9.8 $555,197 - $815,732
83,238 Added 4.1%
2,112,241 $16.8 Million
Q2 2021

Aug 13, 2021

BUY
$5.06 - $10.78 $2.99 Million - $6.37 Million
590,704 Added 41.07%
2,029,003 $15.2 Million
Q1 2021

May 12, 2021

BUY
$5.64 - $23.33 $1.14 Million - $4.73 Million
202,575 Added 16.39%
1,438,299 $8.7 Million
Q4 2020

Feb 12, 2021

BUY
$3.5 - $7.98 $238,633 - $544,084
68,181 Added 5.84%
1,235,724 $7.06 Million
Q3 2020

Nov 13, 2020

BUY
$4.78 - $16.97 $2.47 Million - $8.76 Million
516,141 Added 79.24%
1,167,543 $7.76 Million
Q2 2020

Aug 13, 2020

BUY
$1.68 - $8.85 $525,772 - $2.77 Million
312,960 Added 92.47%
651,402 $5.76 Million
Q1 2020

May 14, 2020

BUY
$0.34 - $2.87 $99,862 - $842,956
293,713 Added 656.65%
338,442 $599,000
Q2 2019

Aug 14, 2019

BUY
$0.63 - $2.04 $14,675 - $47,519
23,294 Added 108.67%
44,729 $29,000
Q2 2018

Aug 14, 2018

BUY
$2.88 - $6.0 $17,928 - $37,350
6,225 Added 40.93%
21,435 $64,000
Q1 2018

May 15, 2018

BUY
$4.95 - $9.02 $75,289 - $137,194
15,210 New
15,210 $77,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $68.3M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.